Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals
Authors:
Open Access
- 1 July 2017
- journal article
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 12 (4) , 344-352
Abstract
No abstract availableKeywords
Funding Information
- Department of Education Liaoning Province (L2013390)
This publication has 19 references indexed in Scilit:
- Physical and chemical stability of drug nanoparticlesAdvanced Drug Delivery Reviews, 2011
- Controlling drug nanoparticle formation by rapid precipitationAdvanced Drug Delivery Reviews, 2011
- Production methods for nanodrug particles using the bottom-up approachAdvanced Drug Delivery Reviews, 2011
- Effects of the Angiotensin Receptor Blocker Azilsartan Medoxomil Versus Olmesartan and Valsartan on Ambulatory and Clinic Blood Pressure in Patients With Stages 1 and 2 HypertensionHypertension, 2011
- In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function StudiesThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Effects of excipient formulation on the morphology and aqueous re-dispersibility of dry-powder silica nano-aggregatesColloids and Surfaces A: Physicochemical and Engineering Aspects, 2010
- Formation, Physical Stability and In Vitro Antimalarial Activity of Dihydroartemisinin Nanosuspensions Obtained by Co-grinding MethodDrug Development and Industrial Pharmacy, 2008
- Experimental investigation of nanoparticle dispersion by beads milling with centrifugal bead separationJournal of Colloid and Interface Science, 2006
- Nanosuspensions in drug deliveryNature Reviews Drug Discovery, 2004
- Nanosuspensions: a promising drug delivery strategyJournal of Pharmacy and Pharmacology, 2004